• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
    All News #Library
    Biotech

    Innate Pharma Shows IPH6501 Activity in Lymphoma at EHA 2025

    BUSINESSWIRE

    Novo Nordisk plans to Start Late-stage Trials of Obesity Drug

    GLOBENEWSWIRE

    Bavarian Nordic Initiates Ph 3 of Chikungunya Vaccine in Children

    GLOBENEWSWIRE

    Moderna Receives U.S. FDA Approval for RSV Vaccine

    REUTERS

    Merck Initiates Phase 3 Study Evaluating Dengue Vaccine Candidate

    BUSINESSWIRE

    GSK Offloads Shigella Vaccine to Bharat Biotech Ahead of Phase 3

    PRESS RELEASE

    Syntimmune Shareholders Win Again Over AZ, time for $181M

    FIERCE BIOTECH

    BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal

    FIERCE BIOTECH

    New CDC Vaccine Advisors Prepare for First Meeting, `Where`s Cass

    BIOSPACE

    IMBRUVICA Combo Shows Edge Over Acalabrutinib in CLL

    GLOBENEWSWIRE

    SNIPR Biome: First Patient Dosed in Phase 1b Trial of SNIPR001

    GLOBENEWSWIRE

    Diagonal Therapeutics to Present Disease-Modifying Data at EHA

    GLOBENEWSWIRE

    Editas Show HBG1/2 Editing With LNP in Sickle Cell & Thalassemia

    GLOBENEWSWIRE

    Enterome raises $19M for OncoMimics™ to treat Follicular Lymphoma

    GLOBENEWSWIRE

    Levicept to Present Phase II Trial Analysis, LEVI-04, at EULAR

    GLOBENEWSWIRE

    I-Mab Complies with Nasdaq Minimum Bid Price Requirement

    GLOBENEWSWIRE

    Nectero Medical Secures CPT Codes for AAA Therapy

    GLOBENEWSWIRE

    Rgenta Therapeutics Presents Preclinical Data from RGT-61159

    GLOBENEWSWIRE

    Third Harmonic Bio Stockholders Approve Liquidation Plan

    GLOBENEWSWIRE

    AIM ImmunoTech Gets US Patent for dsRNA Manufacturing

    GLOBENEWSWIRE

    RadioMedix Introduces ²¹²Pb Generator for Alpha Therapy

    GLOBENEWSWIRE

    Syndax Revumenib BEAT AML Data Out in JCO and EHA 2025

    GLOBENEWSWIRE

    Genmab grants Restricted Stock Units and Warrants to Employees

    GLOBENEWSWIRE

    Starton Opens Ph2a STAR-LLD Trial in Multiple Myeloma

    GLOBENEWSWIRE

    Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025

    GLOBENEWSWIRE

    Celldex Presents 76-Week Results from Barzolvolimab Study at EAAC

    GLOBENEWSWIRE

    BioInvent Presents Phase 2a Data for BI-1808 in CTCL at EHA 2025

    ACCESSWIRE

    Faron Pharmaceuticals updates Phase II data at EHA 2025

    ACCESSWIRE

    ADC Therapeutics Shutters UK R&D site, Lays off 30% of staff

    FIERCE BIOTECH

    Samsung Bioepis Presents EPYSQLI™ Safety Data at EHA Congress

    BUSINESSWIRE

    SpikImm SATT Sign License Deal for BK Virus Prevention

    BUSINESSWIRE

    BeOne Medicines Presents Breakthrough Data in CLL and MCL at EHA

    BUSINESSWIRE

    Galderma Nemluvio Gets NICE Nod for Atopic Dermatitis

    BUSINESSWIRE

    Schrödinger Reports Positive Phase 1 Data for SGR-1505 at EHA

    BUSINESSWIRE

    MiNA Therapeutics Presents New Data at EHA 2025 Congress

    BUSINESSWIRE

    FDA Grants Priority Review for Zoliflodacin NDA for Gonorrhea

    BUSINESSWIRE

    Sensible Biotech Cuts mRNA Optimization Time by Over 90%

    BUSINESSWIRE

    Debiopharm Alkyon Join Forces on Radioligand Therapies

    BUSINESSWIRE

    Rallybio Starts Dosing in RLYB116 Phase 1 PK/PD Study

    BUSINESSWIRE

    AI GLP-1 Peptides From IPA Surpass Semaglutide in Studies

    BUSINESSWIRE

    Infinimmune Debuts GLIMPSE-1 AI for Antibody Engineering

    BUSINESSWIRE

    Parallel Bio Raises $21M in Series A for Human Drug Discovery

    BUSINESSWIRE

    GenSight Gets ANSM Nod for LUMEVOQ Early Access in France

    BUSINESSWIRE

    US FDA Approves UroGen’s Zusduri for Bladder Cancer

    BUSINESSWIRE

    Silence Highlights Ph1 Divesiran Data for Polycythemia Vera

    BUSINESSWIRE

    Quince Therapeutics Prices $22M Private Placement

    BUSINESSWIRE

    EFPIA Urges EU to Streamline Clinical Trials Under Biotech Act

    RAPS

    Fapon Biopharma to Showcase Pipeline Including FP008, at BIO 2025

    PR NEWSWIRE

    ADC Therapeutics Updates Data from LOTIS-7 Trial at EHA 2025

    PR NEWSWIRE

    ADC Therapeutics Announces $100M Private Placement

    PR NEWSWIRE

    Nona Biosciences, Visterra Partner on Next-Gen Biotherapeutics

    PR NEWSWIRE

    Volition Study Shows Nu.Q® H3.1. Linked to Sepsis

    PR NEWSWIRE

    Rebel Medicine Secures Funding and Opens IND for Non-Opioid Pain

    PR NEWSWIRE

    Public Cancer Funding Wanes, Industry Leads Oncology Breakthrough

    PR NEWSWIRE

    Specialised Therapeutics Expands Incyte Deal With 2 Therapies

    PR NEWSWIRE

    UCB Announces US Investment to Expand Biologics Capacity

    PR NEWSWIRE

    Innovent to Present R&D Results at ADA`s 85th Scientific Sessions

    PR NEWSWIRE

    Merry Life Launches Global Phase II Trial of TML-6 of Alzheimer

    PR NEWSWIRE

    EHA: Gearing up for US comeback, GSK details Blenrep`s PFS win

    FIERCE PHARMA

    Dapirolizumab Ph3 SLE Data Shows Less Fatigue & Disease Activity

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.